Sunday, February 13, 2022 6:58:50 AM
Yes , all that was proven million times , and there is a need to talk more . Why ???
Dr Lalezari said many times , and he is very responsive , everyone confused may email him and ask again ..
According to him , protocol for CD12 given to FDA was for 4 doses ..at 0 , 7, 14 and 21 days ..
For no apparent reason FDA refused to approve this way , first they changed to 2 doses , at 0 and at 7 days only , and primary endpoint , mortality , they moved from 14 to 28 days ..
What a perfect sabotage of the protocol , design to fail ..
FDA and Fauci are very good in that , all the studies for HCQ were design to fail .
In CD12 there were 2 official groups .,
A..severe
B..critical
All together in entire CD12 SS was not met , problems noticed later , like wrong age distribution , the oldest patients were in LL arm , and the youngest , the healthiest in placebo ..
Was that an accident , was that another sabotage , was Amarex just neglectful , or was it something more behind this ..
But with all of this we have a very good results in group B , critical patients ., unbelievable good !!!
It was 100% prove that LL saving lives , and not only without one serious side effect , but it look that LL repair some side effects due to some toxic SOC drugs ..
there was less side effects in LL arm , then placebo ( SOC)
What a drug !!
At 14 days there was 82% mortality benefit above all SOC
And even at 28 days , 21 days after the second dose , there was 31% mortality benefit ABOVE all SOC .
And this was with only 62 patients , as we know the smaller the group , the more difficult is to prove benefits , this is why most of the studies of these worthless , toxic drugs are with 1000s of patients , and even then they showing “ trending “
And what FDA do ..
Carrying for American people FDA said , they will not look at “ some “ subgroup results .
They looked and approved “ trending “ results of this toxic drug Remdesivir when Fauci told them .
They show later some positive results , but ONLY when Fauci or Gilead doing the studies , hmmm , interesting …
As FDA said in a hit letter , they will not look at some subgroup good results ..
This subgroup is a group B in CD12 , and the people in it are people on the ventilators and ECMO without one good drug approved for them ..
They all fellow Americans , our families and friends ..
FDA know ( they not stupid ) LL is the ONLY drug saving life’s ., what’s an indifference in this people , observing almost 1 mill death , and doing nothing about it ..
And soon after they approved Biogen drug for Alz..
--Drug showing no clinical significance..
--no primary endpoint,
--no p-value..
And up to 30% of patients developing as a side effect , cerebral edema and/or cerebral bleeding..
What a terrible indifference !!!
What a corruption..
All imo .,
Recent CYDY News
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/13/2024 04:15:06 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 09/07/2024 12:44:56 AM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 09/07/2024 12:42:22 AM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 08/15/2024 09:21:30 PM
- Form SC TO-I/A - Tender offer statement by Issuer: [Amend] • Edgar (US Regulatory) • 07/22/2024 01:00:58 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 07/09/2024 09:17:48 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 07/09/2024 09:16:28 PM
- Form SC TO-I/A - Tender offer statement by Issuer: [Amend] • Edgar (US Regulatory) • 07/09/2024 09:16:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/09/2024 12:46:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 09:15:10 PM
- Form SC TO-I - Tender offer statement by Issuer • Edgar (US Regulatory) • 06/03/2024 09:10:56 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/06/2024 09:17:30 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/06/2024 09:16:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2024 09:09:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2024 02:30:20 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/01/2024 10:16:47 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/01/2024 10:15:34 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 02/22/2024 10:16:11 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 02:00:24 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/12/2024 10:31:57 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/29/2024 10:22:17 PM
FEATURED Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM
North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM
One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM
Element79 Gold Corp Announces 2024 Clover Work Plans & Nevada Portfolio Updates • ELMGF • Sep 10, 2024 11:00 AM